Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma

International Journal of Hematology

Volumn 91, Issue 3, 2010, Pages 426-435

  Asano, Naoko ^a,d,g   Suzuki, Ritsuro ^b   Ohshima, Koichi ^c   Kagami, Yoshitoyo ^a   Ishida, Fumihiro ^d   Yoshino, Tadashi ^e   Ogawa, Hiroshi ^f   Morishima, Yasuo ^a   Nakamura, Shigeo ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

^g SHINSHU UNIVERSITY   (Japan)

Author keywords

ALK negative anaplastic large cell lymphoma (ALCL); Chemokine receptor; Cytotoxic molecule; Peripheral T cell lymphoma, not otherwise specified (PTCL N); Prognosis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTHRACYCLINE DERIVATIVE; CD15 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; EPSTEIN BARR VIRUS ANTIGEN; FASCIN; GRANZYME B; RNA BINDING PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SEX RATIO; T CELL LYMPHOMA; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR4; RECEPTORS, CXCR3; REED-STERNBERG CELLS; SURVIVAL ANALYSIS; TH1 CELLS; TH2 CELLS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77950916814     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0513-0     Document Type: Article

References (39)

1. ES Jaffe NL Harris J Diebold, et al. 1998 World Health Organization classification of lymphomas: a work in progress Ann Oncol 9 S25 S30 10.1023/A:1008462124002 9926234 (Pubitemid 29049114)
2. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
3. Lymphoma study group of Japanese pathologists 2000 The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities Pathol Int 50 696 702 10.1046/j.1440-1827.2000. 01108.x
4. K Ichimura Y Kagami R Suzuki, et al. 2003 Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites Pathol Int 53 333 344 10.1046/j.1440-1827. 2003.01479.x 12787307 (Pubitemid 36859624)
5. RL ten Berge PC de Bruin JJ Oudejans GJ Ossenkoppele P van der Valk CJ Meijer 2003 ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified Histopathology 43 462 469 10.1046/j.1365-2559.2003.01726.x 1:STN:280:DC%2BD3srlslCitA%3D%3D 14636272 (Pubitemid 37445237)
6. RL ten Berge JJ Oudejans GJ Ossenkoppele CJ Meijer 2003 ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects-a review J Pathol 200 4 15 10.1002/path.1331 1:CAS:528: DC%2BD3sXkt1aktLc%3D 12692835 (Pubitemid 36592630)
7. EC Butcher M Williams K Youngman L Rott M Briskin 1999 Lymphocyte trafficking and regional immunity Adv Immunol 72 209 253 10.1016/S0065-2776(08) 60022-X 1:CAS:528:DyaK1MXlsFGksbc%3D 10361577 (Pubitemid 30224828)
8. JJ Campbell EC Butcher 2000 Chemokines in tissue-specific and microenvironment-specific lymphocyte homing Curr Opin Immunol 12 336 341 10.1016/S0952-7915(00)00096-0 1:CAS:528:DC%2BD3cXjsFeqsbc%3D 10781407 (Pubitemid 30240545)
9. L Piali C Weber G LaRosa, et al. 1998 The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig Eur J Immunol 28 961 972 10.1002/(SICI)1521- 4141(199803)28:03<961::AID-IMMU961>3.0.CO;2-4 1:CAS:528:DyaK1cXhvFGitrc%3D 9541591 (Pubitemid 28116209)
10. A Zlotnik O Yoshie 2000 Chemokines: new classification system and their role in immunity Immunity 12 121 127 10.1016/S1074-7613(00)80165-X 1:CAS:528:DC%2BD3cXhslKqsL8%3D 10714678 (Pubitemid 30398626)
11. M Baggiolini 1998 Chemokines and leukocyte traffic Nature 392 565 568 10.1038/33340 1:CAS:528:DyaK1cXis1Smurk%3D 9560152 (Pubitemid 28207705)
12. M Lohning A Stroehmann AJ Coyle, et al. 1998 T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function Proc Natl Acad Sci USA 95 6930 6935 10.1073/pnas.95.12.6930 1:CAS:528:DyaK1cXjslymsrg%3D 9618516 (Pubitemid 28278084)
13. N Odum S Bregenholt KW Eriksen, et al. 1999 The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells Tissue Antigens 54 572 577 10.1034/j.1399-0039.1999.540606.x 1:CAS:528:DC%2BD3cXntFWjtA%3D%3D 10674971 (Pubitemid 30026019)
14. A Zingoni H Soto JA Hedrick, et al. 1998 The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells J Immunol 161 547 551 1:CAS:528:DyaK1cXksFGksbY%3D 9670926 (Pubitemid 28323513)
15. DP Andrew N Rufffing CH Kim, et al. 2001 C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential J Immunol 166 103 111 1:CAS:528: DC%2BD3MXis1amug%3D%3D 11123282
16. R Bonecchi G Bianchi PP Bordignon, et al. 1998 Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 129 134 10.1084/jem.187.1.129 1:CAS:528: DyaK1cXjtV2msQ%3D%3D 9419219 (Pubitemid 28044828)
17. D D'Ambrosio A Iellem R Bonecchi, et al. 1998 Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells J Immunol 161 5111 5115 9820476 (Pubitemid 28519063)
18. S Qin JB Rottman P Myers, et al. 1998 The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 746 754 10.1172/JCI1422 1:CAS:528:DyaK1cXht1Wrsbk%3D 9466968 (Pubitemid 28096070)
19. N Asano R Suzuki Y Kagami, et al. 2005 Clinicopathologic and prognositic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified Am J Surg Pathol 29 1284 1293 10.1097/01.pas.0000173238. 17331.6b 16160469 (Pubitemid 41368762)
20. E Pescarmona P Pignoloni M Puopolo, et al. 2001 p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome J Pathol 195 361 366 10.1002/path.945 1:CAS:528:DC%2BD3MXotlGqu7o%3D 11673835 (Pubitemid 32998363)
21. R Suzuki Y Kagami K Takeuchi, et al. 2000 Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype Blood 96 2993 3000 1:CAS:528:DC%2BD3cXnslGnsbY%3D 11049976
22. Y Kagami R Suzuki H Taji, et al. 1999 Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients Am J Surg Pathol 23 1184 1200 10.1097/00000478-199910000-00003 1:STN:280:DyaK1Mvlt1Wmsg%3D%3D 10524519 (Pubitemid 29474588)
23. E Ralfkiaer A Wollf-Sneedorff K Thomsen C Geisler GL Vejlsgaard 1992 T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study Exp Dermatol 1 31 36 10.1111/j.1600-0625.1992.tb00069.x 1:STN:280:DyaK2c3gslGitw%3D%3D 1344658
24. JR Toro M Beaty L Sorbara, et al. 2000 γδ T-cell lymphoma of the skin: a clinical, microscopic, and molecular study Arch Dermatol 136 1024 1032 10.1001/archderm.136.8.1024 1:STN:280:DC%2BD3cvhs1yktw%3D%3D 10926739 (Pubitemid 30629130)
25. JR Toro DJ Liewehr N Pabby, et al. 2003 Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma Blood 101 3407 3412 10.1182/blood-2002-05-1597 1:CAS:528:DC%2BD3sXjs1aqs7k%3D 12522013 (Pubitemid 36857921)
26. ES Jaffe L Krenacs M Raffeld 2003 Classification of cytotoxic T-cell and natural killer cell lymphomas Semin Hematol 40 175 184 10.1016/S0037-1963(03) 00132-X 1:CAS:528:DC%2BD3sXmsV2ls78%3D 12876666 (Pubitemid 36842595)
27. N Asano A Oshiro K Matsuo, et al. 2006 Prognostic significance of T-cell or cytotoxic phenotype in classical Hodgkin lymphoma: a clinicopathologic study of 324 patients J Clin Oncol 24 4626 4633 10.1200/JCO.2006.06.5342 16954517 (Pubitemid 46630961)
28. T Tsuchiya K Ohshima K Karube, et al. 2004 Th1, Th2 and activated T-cell marker, and clinical prognosis in peripheral T-cell lymphoma, unspecified. Comparison with AILD, ALCL, lymphoblastic lymphoma and ATLL Blood 103 236 241 10.1182/blood-2002-05-1352 1:CAS:528:DC%2BD2cXhsFGitQ%3D%3D 12958063 (Pubitemid 38029944)
29. T Ishida H Inagaki A Utsunomiya, et al. 2004 CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified Clin Cancer Res 10 5494 5500 10.1158/1078-0432.CCR-04-0371 1:CAS:528:DC%2BD2cXmvFSltb8%3D 15328188 (Pubitemid 39100487)
30. D Jones C O'Hara MD Kraus, et al. 2000 Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma Blood 96 685 690 1:CAS:528:DC%2BD3cXltVGhu7Y%3D 10887135 (Pubitemid 30463392)
31. T Ishida A Utsunomiya S Iida, et al. 2003 Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome Clin Cancer Res 9 3625 3634 1:CAS:528:DC%2BD3sXosVOlu7w%3D 14506150 (Pubitemid 37169227)
32. K Ohshima K Karube R Kawano, et al. 2004 Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: Analysis of prognosis Int J Oncol 25 605 613 1:CAS:528:DC%2BD2cXnt1Ohu7o%3D 15289861
33. K Ohshima T Tutiya T Yamaguchi, et al. 2002 Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: relation with expression of CXC and CC chemokines on H&RS cells Int J Cancer 98 565 572 10.1002/ijc.10218 (Pubitemid 34208558)
34. K Ohshima K Karube M Hamasaki, et al. 2003 Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL Int J Cancer 106 706 712 10.1002/ijc.11301 1:CAS:528:DC%2BD3sXms1Squ7k%3D 12866030 (Pubitemid 36993394)
35. NL Harris ES Jaffe H Stein, et al. 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1361 1392 1:STN:280:DyaK2czkvVSmtQ%3D%3D 8068936 (Pubitemid 24273002)
36. O Yoshie T Imai H Nomiyama 2001 Chemokines in immunity Adv Immunol 78 57 110 10.1016/S0065-2776(01)78002-9 1:CAS:528:DC%2BD3MXlsV2kt7c%3D 11432208 (Pubitemid 32566018)
37. C Prezzi MA Casciaro V Francavilla, et al. 2001 Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection Eur J Immunol 31 894 906 10.1002/1521-4141(200103)31:3<894::AID-IMMU894>3.0.CO;2-I 1:CAS:528:DC%2BD3MXitlSmsr4%3D 11241295 (Pubitemid 32237126)
38. J Geginat A Lanzavecchia F Sallusto 2003 Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines Blood 101 4260 4266 10.1182/blood-2002-11-3577 1:CAS:528:DC%2BD3sXktFKht7o%3D 12576317 (Pubitemid 36857786)
39. M Nakata A Kawasaki M Azuma, et al. 1992 Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations Int Immunol 4 1049 1054 10.1093/intimm/4.9.1049 1:STN:280:DyaK3s%2Fgt1Omtw%3D%3D 1356428